Eric Mark Green, President & CEO at WEST PHARMACEUTICAL SERVICES INC (WST), sold 74,600 shares at $395.07 ($29.5M) on 2023-08-08, disclosed to the SEC on 2023-08-10.
Scheduled sale ($29.5M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $389.62 | 1,000 | $390K | 1.3% |
| 2 | $392.16 | 4,500 | $1.8M | 6.0% |
| 3 | $393.13 | 7,055 | $2.8M | 9.4% |
| 4 | $393.13 | 7,055 | $2.8M | 9.4% |
| 5 | $394.17 | 8,329 | $3.3M | 11.1% |
| 6 | $394.17 | 8,329 |
| $3.3M |
| 11.1% |
| 7 | $395.07 | 7,684 | $3.0M | 10.3% |
| 8 | $395.07 | 7,684 | $3.0M | 10.3% |
| 9 | $396.13 | 6,700 | $2.7M | 9.0% |
| 10 | $397.18 | 7,532 | $3.0M | 10.2% |
| 11 | $397.18 | 7,532 | $3.0M | 10.2% |
| 12 | $397.90 | 1,100 | $438K | 1.5% |
| 13 | $398.87 | 100 | $40K | 0.1% |
| Total | $394.82 avg | 74,600 | $29.5M | 100% |
| Filing → |
| WST | SELL | 2024-05-09 | $48.4M | — | Filing → |
| WST | SELL | 2024-02-29 | $46.2M | — | Filing → |
| WST | SELL | 2023-05-11 | $31.8M | — | Filing → |